Baseline | Follow-up | p-value | |
---|---|---|---|
BMI (kg/m2), mean (SD) | 27.1 (4.4) | 26.7 (4.1) | 0.16b * |
WOMAC pain (range 0–100), mean (SD) | 66.8 (21.4) | 69.7 (20.1) | 0.13b |
WOMAC functioning (range 0–100), mean (SD) | 68.3 (19.6) | 67.8 (21.2) | 0.78b |
Medication use, n (%) | |||
Paracetamol | 65 (61.9) | 62 (59.1) | 0.65a |
NSAIDS | 33 (32.4) | 25 (24.5) | 0.08a |
Other | 14 (13.1) | 17 (15.9) | 0.45a |
SQUASH Total activity (min/week), mean (SD) | 2128.9 (1023.1) | 2349.2 (1246.8) | 0.07b |
IPQ Illness perceptions (range 0–100), mean (SD) | 41.3 (10.5) | 39.5 (10.5) | 0.02b * |
GSES Self-efficacy (10–40), mean (SD) | 32.1 (5.9) | 32.2 (5.6) | 0.85b |
PAM-13, patient activation (13–52), mean (SD) | 39.3 (0.5) | 40.1 (0.5) | 0.15b |
Knowledge on OA (0–22), mean (SD) | 10.5 (3.7) | 12.9 (3.1) | 0.00b * |